Catherine Scholz
Global Development Team Leader | Biopharma Executive | Portfolio Strategist
- Role
- Vice President, Product Team Leader at Day One Biopharmaceuticals
- Location
- North Reading, MA, US
- LinkedIn followers
- 500 followers
About Catherine Scholz
Strategic drug development executive with >20 yr of biopharma experience and a successful track record of delivering competitively differentiated, therapeutically meaningful and commercially attractive assets in oncology and immunology. • Global development team leader (>14 yr) with expertise from discovery through commercial launch• Clinical Pharmacologist for the development and worldwide approvals of vedolizumab (Entyvio®), brentuximab vedotin (Adcetris®) and estradiol valerate/dienogest (Qlaira®).
Experience
Vice President, Product Team Leader
Jul 2024 — Present · Boston, MA, US
OJEMDA™ (Tovorafenib) Product Team Lead- DAY301 Product Team Lead
Education
Rutgers University
Doctor of Pharmacy and BS, Pharmacy with Honors
1995 — 2001
Skills
- R&D
- Infectious Diseases
- Oncology
- Clinical Research
- Clinical Pharmacology
- Therapeutic Areas
- Ich-Gcp
- Pharmacology
- Ctms
- Regulatory Submissions
- Medical Writing
- Clinical Development
- Drug Discovery
- Translational Medicine
- Biotherapeutics
- Pharmaceutical Industry
- Fda
- Pharmacovigilance
- U.s. Food and Drug Administration (Fda)
- Biotechnology
- Drug Development
- Biologics
- Cancer
- Gcp
- Biopharmaceuticals
- Clinical Trials
- CRO
- Translational Research
- Cross-Functional Team Leadership
- Medical Affairs
- Pharmacokinetics
- Regulatory Affairs
- Lifesciences
- Good Clinical Practice (Gcp)
- Ind
- Glp
- CRO Management
- Clinical Monitoring
- Biomarkers
- Clinical Study Design
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.